Cancer Sciences at Cleveland Clinic brings together basic scientists, translational researchers, and clinicians to tackle some of the most complex and pressing challenges in oncology. As one of the largest cancer research departments in the country, our dedicated staff collaborates to identify emerging cancer treatments using advanced methodologies, data and technology. Our integrative approach means discoveries are quickly translated to patient care through clinical trials and more.
Discover more about our programCancer Sciences at Cleveland Clinic studies the molecular and systems levels of cancer to gain translational insights that lead to better outcomes for patients. Our goal is to accelerate discovery and develop clinical trials based on our discoveries.
We are committed to using research and translation to improve the lives of patients and families affected by cancer.
We leverage cutting-edge technologies in all that we do.
Partnering with the Cancer Institute, we provide key services for the institution including:
Discovery and collaboration are at the heart of our work, with interdisciplinary teams working together to build mechanistic insight and therapeutic innovation.
Focus AreasCancer researchers at the Cleveland Clinic Abu Dhabi campus are focused on developmental therapeutics and translational research. Investigators focus on tumor immunology, clinical trials, and heavy ion research at one of the few carbon ion treatment facilities in the world.
Learn about our locations
New research reveals that the PAR4 receptor is connected to sex-specific immune responses.
DNA polymerase iota (Pol i) is involved in helping breast cells respond to stress, offering insights into the earliest biological changes associated with inherited breast cancer risk.
Bacteria living inside tumors can influence immunity, treatment response and disease progression. Cleveland Clinic is figuring out whether modifying those bacterial communities can improve outcomes.